Viewing Study NCT01998503


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2026-02-21 @ 12:13 AM
Study NCT ID: NCT01998503
Status: COMPLETED
Last Update Posted: 2013-11-29
First Post: 2013-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis
Sponsor: Nanjing University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Amyloidosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AL amyloidosis View
None bortezomib View
None autologous stem cell transplantation View